we screen proteomes against billions of molecules

get access to our data and ML models to launch your next discovery program.

Identify therapeutic opportunities instantly for disease targets of interest

access billions of protein and small molecule interaction data points, all generated internally at Om.

No more waiting
to screen a protein from scratch

We leverage synthetic biology and pico-scale engineering to screen hundreds of proteins against billions of molecules.

384

proteins screened per week

No more waiting
for molecular starting points

We characterize millions of interactions at the pico-scale to identify what small molecules bind what proteins.

350M

molecules tested per protein

No more waiting
for data to make next decisions

Billions of data points per week can be used to train ML models, that can improve with each re-training.

>100B

data points per week

ML training sets at unparalleled speed & scale.

  • + Synthetic Biology
  • + Molecular Encoding
  • + Pico-Scale Engineering
  • + AI

Our technology leverages synthetic biology, pico-scale engineering, materials science, and molecular encoding to screen thousands of proteins against billions of molecules in a single reaction. We are leveraging these datasets to train machine learning models to predict molecular interactions at scale.

Animated atoms

Go from hypothesis to launching a discovery program, in weeks.

We're screening entire proteomes against billions of molecules ahead of time, so you don't have to.

Available Now

Diligence

Our Tool

Our diligence tool helps you avoid reading hundreds of disparate publications, so you can focus on the information that matters.

Our Tool

Origin API

We're screening hundreds of proteins a week against >350M molecules. Get access to all of this data to identify what molecules bind what proteins, and launch your next discovery program with a query.

Latest
Articles

View more

Who is Om?

Who is Om?

Om was built to solve the data problem everyone shares in therapeutic discovery, so that we can find new medicines faster.

April 30, 2025 . 6 min read

Om Launches Diligence

Om Launches Diligence

We did therapeutic diligence on the entire proteome, by reading thousands of publications and synthesizing the data so you don’t have to.

April 30, 2025 . 6 min read

Om opens up early access for customers

Om opens up early access for customers

We are excited to announce that we are opening up early access for customers to our platform, so that they can generate data points at scale on their proteins of interest.

April 30, 2025 . 6 min read

Input target, Output diligence.

Identify targets in need of a new medicine, fast.

Diligence

FAQs

When we started building Om, we had a huge list of roughly 17K proteins we were going to screen with our initial encoded libraries of hundreds of milliosn of molecules -- but we wanted to make sure we screened the proteins that most needed data. So we built out a tool to rank order the 17K by doing automated diligence on therapeutic opportunities for all of the proteins on the list. We provided this to some early users, and they wanted access to the tool to screen their own lists of proteins. So we built out Diligence.

API

FAQs